134 related articles for article (PubMed ID: 29961117)
1. Retrospective analysis of primarily treated group D retinoblastoma.
Kiratli H; Koç İ; Inam O; Varan A; Akyüz C
Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2225-2231. PubMed ID: 29961117
[TBL] [Abstract][Full Text] [Related]
2. Unilateral Retinoblastoma Managed With Intravenous Chemotherapy Versus Intra-Arterial Chemotherapy. Outcomes Based on the International Classification of Retinoblastoma.
Shields CL; Jorge R; Say EA; Magrath G; Alset A; Caywood E; Leahey AM; Jabbour P; Shields JA
Asia Pac J Ophthalmol (Phila); 2016; 5(2):97-103. PubMed ID: 26765038
[TBL] [Abstract][Full Text] [Related]
3. Globe salvage treatment in group D and group E retinoblastoma.
Hussain AK; Rahul RA; Carlos RL; Francisco ZM; María GL; Flavia P; Chiara B; Davide B
Rom J Ophthalmol; 2021; 65(1):20-24. PubMed ID: 33817429
[No Abstract] [Full Text] [Related]
4. Chemotherapy for Retinoblastoma: Impact of Intravitreal Chemotherapy.
Raval V; Bowen RC; Soto H; Singh A
Asia Pac J Ophthalmol (Phila); 2020 Sep; 10(2):200-202. PubMed ID: 32925294
[TBL] [Abstract][Full Text] [Related]
5. Intra-Arterial Chemotherapy for Retinoblastoma: 8-Year Experience from a Tertiary Referral Institute in Thailand.
Rojanaporn D; Chanthanaphak E; Boonyaopas R; Sujirakul T; Hongeng S; Ayudhaya SSN
Asia Pac J Ophthalmol (Phila); 2019; 8(3):211-217. PubMed ID: 30714357
[TBL] [Abstract][Full Text] [Related]
6. Angiographic characteristics and treatment approach in patients undergoing intra-arterial chemotherapy for retinoblastoma.
Rusakevich AM; Nahhas MI; Zhou B; Dannenbaum MJ; Bretana ME; Schefler AC
Graefes Arch Clin Exp Ophthalmol; 2024 Apr; 262(4):1321-1328. PubMed ID: 38032379
[TBL] [Abstract][Full Text] [Related]
7. Efficacy, Toxicity, and Pharmacokinetics of Intra-Arterial Chemotherapy Versus Intravenous Chemotherapy for Retinoblastoma in Animal Models and Patients.
Daniels AB; Froehler MT; Kaczmarek JV; Bogan CM; Santapuram PR; Pierce JM; Chen SC; Schremp EA; Boyd KL; Tao YK; Calcutt MW; Koyama T; Richmond A; Friedman DL
Transl Vis Sci Technol; 2021 Sep; 10(11):10. PubMed ID: 34495330
[TBL] [Abstract][Full Text] [Related]
8. Retinoblastoma frontiers with intravenous, intra-arterial, periocular, and intravitreal chemotherapy.
Shields CL; Fulco EM; Arias JD; Alarcon C; Pellegrini M; Rishi P; Kaliki S; Bianciotto CG; Shields JA
Eye (Lond); 2013 Feb; 27(2):253-64. PubMed ID: 22995941
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma Based on Patient Age in 964 Eyes of 554 Patients.
Bas Z; Dalvin LA; Tadepalli S; Rao R; Shah A; Leahey AM; Shields CL
Asia Pac J Ophthalmol (Phila); 2021 Jan; 10(4):373-380. PubMed ID: 33481399
[TBL] [Abstract][Full Text] [Related]
10. Ocular Salvage and Vision Preservation Using a Topotecan-Based Regimen for Advanced Intraocular Retinoblastoma.
Brennan RC; Qaddoumi I; Mao S; Wu J; Billups CA; Stewart CF; Hoehn ME; Rodriguez-Galindo C; Wilson MW
J Clin Oncol; 2017 Jan; 35(1):72-77. PubMed ID: 28034080
[TBL] [Abstract][Full Text] [Related]
11. Thermochemotherapy in hereditary retinoblastoma.
Schueler AO; Jurklies C; Heimann H; Wieland R; Havers W; Bornfeld N
Br J Ophthalmol; 2003 Jan; 87(1):90-5. PubMed ID: 12488270
[TBL] [Abstract][Full Text] [Related]
12. Improving survival of retinoblastoma in Uganda.
Waddell KM; Kagame K; Ndamira A; Twinamasiko A; Picton SV; Simmons IG; Revill P; Johnston WT; Newton R
Br J Ophthalmol; 2015 Jul; 99(7):937-42. PubMed ID: 25583281
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for cataract in retinoblastoma management.
Jia S; Wen X; Yu J; Zhou M; Yang L; Feng Y; He X; Jia R; Fan J; Fan X
Br J Ophthalmol; 2024 Mar; 108(4):571-577. PubMed ID: 37068919
[TBL] [Abstract][Full Text] [Related]
14. Update on chemotherapy modalities for retinoblastoma: Progress and challenges.
Kritfuangfoo T; Rojanaporn D
Asia Pac J Ophthalmol (Phila); 2024; 13(2):100061. PubMed ID: 38641204
[TBL] [Abstract][Full Text] [Related]
15. Advancements in super-selective catheterization and drug selection for intra-arterial chemotherapy for retinoblastoma: a 15-year evolution.
Kocharian G; Gobin YP; Kharas N; Knopman J; Francis JH; Abramson DH
J Neurointerv Surg; 2024 Mar; 16(4):398-404. PubMed ID: 37197934
[TBL] [Abstract][Full Text] [Related]
16. Retinoblastoma in Asia: Clinical Presentation and Treatment Outcomes in 2112 Patients from 33 Countries.
Kaliki S; Vempuluru VS; Mohamed A; Al-Jadiry MF; Bowman R; Chawla B; Hamid SA; Ji X; Kapelushnik N; Kebudi R; Sthapit PR; Rojanaporn D; Sitorus RS; Yousef YA; Fabian ID;
Ophthalmology; 2024 Apr; 131(4):468-477. PubMed ID: 37839559
[TBL] [Abstract][Full Text] [Related]
17. Unilateral retinoblastoma; natural history and an age-based protocol in 248 patients.
El Zomor H; Nour R; Saad A; Taha H; Shelil AE; Aleieldin A; Saad Zaghloul M; Alfaar AS
Eye (Lond); 2021 Sep; 35(9):2564-2572. PubMed ID: 33188294
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and survival among children with retinoblastoma in Uganda.
Waddell KM; Kagame K; Ndamira A; Twinamasiko A; Picton SV; Simmons IG; Johnston WT; Newton R
Br J Ophthalmol; 2015 Mar; 99(3):387-90. PubMed ID: 25217695
[TBL] [Abstract][Full Text] [Related]
19. Expression of heat shock protein 27 and alpha-crystallins in human retinoblastoma after chemoreduction.
Kase S; Parikh JG; Rao NA
Br J Ophthalmol; 2009 Apr; 93(4):541-4. PubMed ID: 18812387
[TBL] [Abstract][Full Text] [Related]
20. Advanced Interventional Treatments in Retinoblastoma Management: A Comprehensive Review.
Kolyvas P; Mir A; Stirrat T; Brookner B; Pilar N; Monroe E; Ahuja R
Cardiovasc Intervent Radiol; 2024 Apr; 47(4):407-415. PubMed ID: 38509339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
